Independent Director · Tonix Pharmaceuticals Holding Corp. (TNXP)

Newcomb Stillwell — Tonix Pharmaceuticals Director Compensation (2025)

Fiscal year 2025 director compensation for Newcomb Stillwell at Tonix Pharmaceuticals Holding Corp.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 30, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Tonix Pharmaceuticals Director Compensation Table · the one fiscal year held
In US dollars, as Tonix Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$55,000—$188,830—$243,830

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tonix Pharmaceuticals Holding Corp. DEF 14A filed March 30, 2026, accession 0001999371-26-007108, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

Tonix Pharmaceuticals pays directors a $55,000 cash retainer and $188,830 in Options.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance

The rest of the Tonix Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Adeoye OlukotunIndependent Director$243,830
Carolyn TaylorIndependent Director$243,830
David GrangeIndependent Director$243,830
James HunterIndependent Director$280,207
James TrecoLead Independent Director$263,830
Margaret Smith BellIndependent Director$243,830
Richard BaggerIndependent Director$243,830
Seth LedermanChair of the Board$0

The full Tonix Pharmaceuticals compensation record

free company brief

This page is one director within Tonix Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy